Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil

Several COVID-19 vaccines have shown good efficacy in clinical trials, but there remains uncertainty about the efficacy of vaccines against different variants. Here, we investigate the efficacy of ChAdOx1 nCoV-19 (AZD1222) against symptomatic COVID-19 in a post-hoc exploratory analysis of a Phase 3...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar:	Clemens, SAC, Folegatti, PM, Emary, KRW, Weckx, LY, Ratcliff, J, Bibi, S, Verena De Almeida Mendes, A, Milan, EP, Pitella, A, Schwarzbold, AV, Sprinz, E, Aley, PK, Bonsall, D, Fraser, C, Fuskova, M, Gilbert, SC, Jenkin, D, Kelly, S, Kerridge, S, Lambe, T, Marchevsky, NG, Mujadidi, YF, Plested, E, Ramasamy, MN, Simmonds, P, Golubchik, T, Voysey, M, Pollard, AJ
Diğer Yazarlar:	AMPHEUS Project
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Springer Nature 2021

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil

Benzer Materyaller